Palvella Therapeutics PVLA
$142.85 −$2.92 (-2.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $142.85 0.00%
Open$143.10
Prev close$145.77
Day range$142.22 – $148.69
Volume192.7K
Market cap$2.09B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±5.5%last 8 reports
Closed higher3 of 838% of the time
Best reaction+12.6%
Worst reaction-13.0%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 5 Nov 2026 | Pre Market | ±8.8% | -3.35% | Within range |
| 2026/Q2 | 4 Aug 2026 | Pre Market | ±11.1% | +7.96% | Within range |
| 2026/Q1 | 7 May 2026 | Pre Market | ±8.4% | -12.99% | Bigger than priced |
| 2025/Q4 | 31 Mar 2026 | Pre Market | ±12.2% | +12.64% | Bigger than priced |
| 2025/Q3 | 11 Nov 2025 | Pre Market | ±10.0% | -3.04% | Within range |
| 2025/Q2 | 14 Aug 2025 | Pre Market | – | +3.27% | – |
| 2025/Q1 | 15 May 2025 | Pre Market | – | -0.41% | – |
| 2024/Q4 | 31 Mar 2025 | Pre Market | – | -0.39% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$22.73M-123.3% YoY
Net profit-$24.64M-117.2% YoY
Diluted EPS-$1.70-65.0% YoY
Free cash flow-$14.43M-83.1% YoY
Operating cash flow-$14.43M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Return on equity-63.4%
Return on assets-49.0%
Return on invested capital-60.8%
Current ratio16.01
Liabilities / assets17.3%
Cash & investments$236.68M
Total debt$260,000.00
Net cash (debt)$236.42M
No comments yet — be the first to weigh in on PVLA.
Sign in to join the discussion.